Clinuvel Pharmaceuticals Limited

Hello everyone, thank you for joining CleanWell's investor webinar. I am Stella of Monsoon Communications. In today's webinar, CleanWell will share their financial year 2025 results and operational highlights for year ended on 30th June 2025. Many have asked questions as you registered for the webinar, which may still be tabled during the session through the Q&A function. I will now hand over to Malcolm Bull, Head of Investor Relations and Australian Operations, to conduct the proceedings.

Thank you for the introduction, Stella, and also thanks to Monson Communications, who are facilitating yet another investor webinar for us. It's pleasing we have more than 190 participants on the line from around the world, and we thank you for your interest in Plinyaville. I will say that some shareholders have told us they prefer a shorter 30 minute type webinar but we have extended today's webinar at the request of several institutions to 45 minutes and that reflects the number of questions that we've received as well. So our webinar will be in three parts. The first part is to discuss the financial and operating results of the 2025 financial year, as Stella mentioned, with Managing Director, Dr. Philippe Walden, and Chief Financial Officer, Peter Vaughan. Welcome, gentlemen.

Good morning and good evening.